Amphastar Pharmaceuticals AMPH Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $170.18M+12.2% | $151.61M+5.1% | $144.3M-7.6% | $156.1M+23.5% | ||
| $112.64M+60.8% | $70.04M-37.8% | $112.51M+472% | $19.66M+90.5% | ||
| $235K0.0% | $235K0.0% | $235K0.0% | $235K0.0% | ||
| $143.56M+5.3% | $136.29M+18.6% | $114.94M+29.4% | $88.8M+12.7% | ||
| $176.89M+15.1% | $153.74M+45.3% | $105.83M+2.2% | $103.58M+11.6% | ||
| $13.15M-27.8% | $18.21M+101% | $9.06M+19.8% | $7.56M+4.0% | ||
| $636.02M+19.1% | $534.07M+9.1% | $489.6M+29.4% | $378.32M+18.9% | ||
| $310.57M+4.4% | $297.35M+5.2% | $282.75M+18.7% | $238.27M-2.4% | ||
| $42.93M-8.5% | $46.9M+45.0% | $32.33M+26.5% | $25.55M-5.0% | ||
| $565.97M-4.2% | $590.66M-3.7% | $613.3M+1,544% | $37.3M-4.0% | ||
| $31.14M+19.8% | $25.99M+0.3% | $25.91M+24.2% | $20.86M+25.1% | ||
| $1.63B+3.3% | $1.58B+4.3% | $1.51B+104% | $741.99M+10.5% | ||
| $148.35M-5.5% | $157.06M+68.2% | $93.37M+10.8% | $84.24M-5.9% | ||
| $1.64M+601% | $234K-46.3% | $436K-85.7% | $3.05M+38.3% | ||
| $7.93M+16.5% | $6.8M+74.2% | $3.91M+30.1% | $3M+0.7% | ||
| $158.16M-9.0% | $173.76M-22.9% | $225.41M+138% | $94.86M-8.6% | ||
| $608.75M+1.2% | $601.63M+2.0% | $589.58M+709% | $72.84M-2.6% | ||
| $37.68M-10.0% | $41.88M+40.9% | $29.72M+25.4% | $23.69M-4.1% | ||
| $45.61M-6.3% | $48.69M+44.8% | $33.63M+26.0% | $26.7M-3.6% | ||
| $264K-38.9% | $432K-29.9% | $616K-22.0% | $790K+98.5% | ||
| $29.98M+43.1% | $20.95M-7.8% | $22.72M+56.0% | $14.57M-7.0% | ||
| $840.49M-0.6% | $845.17M-3.2% | $873.49M+309% | $213.33M-5.6% | ||
| $6K0.0% | $6K0.0% | $6K0.0% | $6K0.0% | ||
| $535.38M+5.9% | $505.4M+4.0% | $486.06M+6.8% | $455.08M+7.7% | ||
| $666.88M+17.2% | $568.79M+39.0% | $409.27M+50.6% | $271.72M+50.7% | ||
| -$5.31M+42.1% | -$9.18M-8.3% | -$8.48M+1.7% | -$8.62M-27.5% | ||
| $408.15M+22.7% | $332.71M+34.5% | $247.43M+30.6% | $189.52M+25.9% | ||
| $1.63B+3.3% | $1.58B+4.3% | $1.51B+104% | $741.99M+10.5% | ||
| $17.17M+883% | $1.75M+232% | $526K+208% | $171K+35.7% | ||
| $2.2M0.0% | $2.2M0.0% | $2.2M0.0% | $2.2M0.0% | ||
| $31.14M+19.8% | $25.99M+0.3% | $25.91M+24.2% | $20.86M+25.1% | ||
| $565.97M-4.2% | $590.66M-3.7% | $613.3M+1,544% | $37.3M-4.0% | ||
| $42.93M-8.5% | $46.9M+45.0% | $32.33M+26.5% | $25.55M-5.0% | ||
| $42.46M-40.3% | $71.12M+33.6% | $53.25M+38.2% | $38.53M+72.0% | ||
| $565.97M-4.2% | $590.66M-3.7% | $613.3M+1,544% | $37.3M-4.0% | ||
| $42.93M-8.5% | $46.9M+45.0% | $32.33M+26.5% | $25.55M-5.0% | ||
| $31.14M+19.8% | $25.99M+0.3% | $25.91M+24.2% | $20.86M+25.1% | ||
| $112.64M+60.8% | $70.04M-37.8% | $112.51M+472% | $19.66M+90.5% | ||
| $42.93M-8.5% | $46.9M+45.0% | $32.33M+26.5% | $25.55M-5.0% | ||
| $31.14M+19.8% | $25.99M+0.3% | $25.91M+24.2% | $20.86M+25.1% | ||
| $148.35M-5.5% | $157.06M+68.2% | $93.37M+10.8% | $84.24M-5.9% | ||
| $239K-97.5% | $9.66M+501% | $1.61M-64.8% | $4.57M-49.7% | ||
| $1.64M+601% | $234K-46.3% | $436K-85.7% | $3.05M+38.3% | ||
| $608.75M+1.2% | $601.63M+2.0% | $589.58M+709% | $72.84M-2.6% | ||
| $656.27M+0.8% | $650.98M+4.3% | $624.26M+504% | $103.37M-1.6% | ||
| $6K0.0% | $6K0.0% | $6K0.0% | $6K0.0% | ||
| $408.15M+22.7% | $332.71M+34.5% | $247.43M+30.6% | $189.52M+25.9% | ||
| $5.93M-14.8% | $6.96M+14.7% | $6.07M-16.0% | $7.23M+10.6% | ||
| $221K-42.3% | $383K-32.1% | $564K-25.1% | $753K+113% | ||
| $608.75M+1.2% | $601.63M+2.0% | $589.58M+709% | $72.84M-2.6% | ||
| $1.64M+601% | $234K-46.3% | $436K-85.7% | $3.05M+38.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Amphastar Pharmaceuticals's total assets?
- Amphastar Pharmaceuticals (AMPH) holds $1.6B in total assets, up 1.4% year over year.
- How much cash does Amphastar Pharmaceuticals have?
- Amphastar Pharmaceuticals holds $170.9M in cash and equivalents.
- Can Amphastar Pharmaceuticals cover its short-term obligations?
- Its current ratio is 3.85 — current assets exceed current liabilities.
- Where does Amphastar Pharmaceuticals's balance sheet data come from?
- Every line is extracted from Amphastar Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
